InsidersTradesSigma
Follow the 리센스메디컬 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 리센스메디컬 has published 10 public disclosures. Market capitalisation: €114.5bn. The latest transaction was filed on 30 June 2026 (Purchase). Among the most active insiders: 김건호. Every trade is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 June 2026
Declarations10 total
Other
10 of 10 declarations
关于 리센스메디컬
리센스메디컬 是一家在医疗保健和制药领域运营的公司，在 XKRX 市场上市。该公司专注于开发创新的医疗解决方案。